Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Classical hematology 2

Conditions

Venous Thromboembolism 4Venous Thrombosis 2Pulmonary Embolism 2Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Thrombosis 1Thromboembolism 1Sarcoma 1Ovarian Neoplasms 1Lung Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Dalteparin 7apixaban 5edoxaban 4Rivaroxaban 3Enoxaparin 3Tinzaparin 2Heparin 2Fondaparinux 2Dabigatran 2calcium heparin 1bemiparin 1Warfarin 1Ultrasonography, Doppler, Duplex 1Rosuvastatin Calcium 1Nadroparin 1Heparin, Low-Molecular-Weight 1Data Collection 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Venous Thrombosis × Fondaparinux × Clear all
NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT01444612 2017-05-16

Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery

GlaxoSmithKline

Completed
4,068 enrolled
Classical hematology

Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡